• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有 88.3%光热转换效率的近红外光驱动无阻碍纳米颗粒群体旋转用于光热治疗。

NIR Light-Driving Barrier-Free Group Rotation in Nanoparticles with an 88.3% Photothermal Conversion Efficiency for Photothermal Therapy.

机构信息

State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, Hi-Tech Zone, Dalian, 116024, China.

State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China.

出版信息

Adv Mater. 2020 Mar;32(11):e1907855. doi: 10.1002/adma.201907855. Epub 2020 Feb 5.

DOI:10.1002/adma.201907855
PMID:32022978
Abstract

Traditional photothermal therapy requires high-intensity laser excitation for cancer treatments due to the low photothermal conversion efficiency (PCE) of photothermal agents (PTAs). PTAs with ultra-high PCEs can decrease the required excited light intensity, which allows safe and efficient therapy in deep tissues. In this work, a PTA is synthesized with high PCE of 88.3% based on a BODIPY scaffold, by introducing a CF "barrier-free" rotor on the meso-position (tfm-BDP). In both the ground and excited state, the CF moiety in tfm-BDP has no energy barrier to rotation, allowing it to efficiently dissipate absorbed (NIR) photons as heat. Importantly, the barrier-free rotation of CF can be maintained after encapsulating tfm-BDP into polymeric nanoparticles (NPs). Thus, laser irradiation with safe intensity (0.3 W cm , 808 nm) can lead to complete tumor ablation in tumor-bearing mice after intravenous injection of tfm-BDP NPs. This strategy of "barrier-free rotation" provides a new platform for future design of PTT agents for clinical cancer treatment.

摘要

传统的光热疗法由于光热剂(PTAs)的光热转换效率(PCE)低,因此需要高强度激光激发来进行癌症治疗。具有超高 PCE 的 PTAs 可以降低所需的激发光强度,从而允许在深部组织中进行安全有效的治疗。在这项工作中,基于 BODIPY 支架合成了一种 PTA,其 PCE 高达 88.3%,通过在中位(tfm-BDP)上引入 CF“无阻碍”转子。在基态和激发态下,tfm-BDP 中的 CF 部分没有旋转的能量障碍,使其能够有效地将吸收的(近红外)光子转化为热量。重要的是,将 tfm-BDP 封装在聚合物纳米颗粒(NPs)中后,无阻碍旋转的 CF 可以保持。因此,静脉注射 tfm-BDP NPs 后,用安全强度(0.3 W cm, 808nm)的激光照射可以导致荷瘤小鼠的肿瘤完全消融。这种“无阻碍旋转”策略为未来用于临床癌症治疗的 PTT 剂的设计提供了新的平台。

相似文献

1
NIR Light-Driving Barrier-Free Group Rotation in Nanoparticles with an 88.3% Photothermal Conversion Efficiency for Photothermal Therapy.具有 88.3%光热转换效率的近红外光驱动无阻碍纳米颗粒群体旋转用于光热治疗。
Adv Mater. 2020 Mar;32(11):e1907855. doi: 10.1002/adma.201907855. Epub 2020 Feb 5.
2
Near-Infrared Light-Driving Organic Photothermal Agents with an 88.9% Photothermal Conversion Efficiency for Image-Guided Synergistic Phototherapy.近红外光驱动光热剂,具有 88.9%的光热转换效率,用于图像引导的协同光热治疗。
Adv Healthc Mater. 2024 Jul;13(19):e2400201. doi: 10.1002/adhm.202400201. Epub 2024 Mar 31.
3
Making the Brightest Ones Dim: Maximizing the Photothermal Conversion Efficiency of BODIPY-Based Photothermal Agents.使最亮的光变暗:最大化基于 BODIPY 的光热试剂的光热转换效率。
Adv Healthc Mater. 2024 Jul;13(19):e2400885. doi: 10.1002/adhm.202400885. Epub 2024 Apr 12.
4
Highly stable organic photothermal agent based on near-infrared-II fluorophores for tumor treatment.基于近红外二区荧光染料的高稳定性有机光热试剂用于肿瘤治疗。
J Nanobiotechnology. 2021 Feb 4;19(1):37. doi: 10.1186/s12951-021-00782-y.
5
Acceptor-donor-acceptor type organic photothermal agents with enhanced NIR absorption and photothermal conversion effect for cancer photothermal therapy.具有增强的近红外吸收和光热转换效果的给体-受体-给体型有机光热剂用于癌症光热治疗。
Talanta. 2024 Jul 1;274:125991. doi: 10.1016/j.talanta.2024.125991. Epub 2024 Mar 27.
6
The tumor phototherapeutic application of nanoparticles constructed by the relationship between PTT/PDT efficiency and 2,6- and 3,5-substituted BODIPY derivatives.基于 PTT/PDT 效率与 2,6- 和 3,5-取代 BODIPY 衍生物关系构建的纳米粒子在肿瘤光疗中的应用。
J Mater Chem B. 2021 Sep 22;9(36):7461-7471. doi: 10.1039/d1tb01155c.
7
Electron-Withdrawing Substituents Enhance the Type I PDT and NIR-II Fluorescence of BODIPY J Aggregates for Bioimaging and Cancer Therapy.吸电子取代基增强 BODIPY J 聚集体的 I 型 PDT 和 NIR-II 荧光用于生物成像和癌症治疗。
Nano Lett. 2024 Jul 10;24(27):8287-8295. doi: 10.1021/acs.nanolett.4c01339. Epub 2024 Jun 28.
8
BF-Bridged Azafulvene Dimer-Based 1064 nm Laser-Driven Superior Photothermal Agent for Deep-Seated Tumor Therapy.基于BF桥连氮杂富烯二聚体的1064纳米激光驱动的深部肿瘤治疗优质光热剂
Angew Chem Int Ed Engl. 2024 Aug 19;63(34):e202407307. doi: 10.1002/anie.202407307. Epub 2024 Jul 24.
9
Aggregation-Induced Emission-Active Organic Nanoagent with High Photothermal Conversion Efficiency for Near-Infrared Imaging-Guided Tumor Photothermal Therapy.具有高光热转换效率的聚集诱导发射活性有机纳米剂,用于近红外成像引导的肿瘤光热治疗。
ACS Biomater Sci Eng. 2024 Oct 14;10(10):6210-6217. doi: 10.1021/acsbiomaterials.4c00959. Epub 2024 Sep 10.
10
Conjugated BODIPY Oligomers with Controllable Near-Infrared Absorptions as Promising Phototheranostic Agents through Excited-State Intramolecular Rotations.通过激发态分子内旋转制备具有近红外吸收可控性的共轭 BODIPY 低聚物作为有前途的光热治疗试剂。
ACS Appl Mater Interfaces. 2020 Oct 21;12(42):47208-47219. doi: 10.1021/acsami.0c11701. Epub 2020 Oct 9.

引用本文的文献

1
N-doped carbon dots for dual-modality NIR fluorescence imaging and photothermal therapy.用于双模态近红外荧光成像和光热治疗的氮掺杂碳点
J Nanobiotechnology. 2025 Jul 15;23(1):513. doi: 10.1186/s12951-025-03497-6.
2
Smart molecular probes with controllable photophysical property for smart medicine.用于智能医学的具有可控光物理性质的智能分子探针。
Smart Mol. 2024 Sep 4;2(3):e20240033. doi: 10.1002/smo.20240033. eCollection 2024 Sep.
3
Dual-acceptor engineering of donor-acceptor type molecules for all-round boosting anti-tumor phototherapy.
用于全面增强抗肿瘤光疗的给体-受体型分子的双受体工程
Smart Mol. 2023 Nov 23;2(2):e20230014. doi: 10.1002/smo.20230014. eCollection 2024 Jun.
4
PA/MR imaging-guided precision phototherapy and efficacy evaluation of hepatocellular carcinoma utilizing a targeted multifunctional nanoprobe.基于靶向多功能纳米探针的PA/MR成像引导下肝癌精准光疗及疗效评估
Front Immunol. 2025 Jun 11;16:1605048. doi: 10.3389/fimmu.2025.1605048. eCollection 2025.
5
In-silico study of lanthanide-based nanoparticles for dual-modal photoacoustic and MRI theranostics.基于镧系元素的纳米颗粒用于双模态光声和磁共振成像诊疗的计算机模拟研究
Sci Rep. 2025 May 29;15(1):18818. doi: 10.1038/s41598-025-01530-0.
6
Multifunctional and Scalable Nanoparticles for Bimodal Image-Guided Phototherapy in Bladder Cancer Treatment.用于膀胱癌治疗中双模态图像引导光疗的多功能可扩展纳米颗粒。
Nanomicro Lett. 2025 Apr 18;17(1):222. doi: 10.1007/s40820-025-01717-0.
7
Readily constructed squaraine J-aggregates with an 86.0 % photothermal conversion efficiency for photothermal therapy.易于构建的方酸菁 J 聚集体,用于光热治疗,光热转换效率达 86.0%。
Bioact Mater. 2024 Oct 10;43:460-470. doi: 10.1016/j.bioactmat.2024.09.031. eCollection 2025 Jan.
8
Pyridinium Rotor Strategy toward a Robust Photothermal Agent for STING Activation and Multimodal Image-Guided Immunotherapy for Triple-Negative Breast Cancer.用于激活STING及三阴性乳腺癌多模态图像引导免疫治疗的稳健光热剂的吡啶鎓转子策略
J Am Chem Soc. 2025 Mar 5;147(9):7433-7444. doi: 10.1021/jacs.4c15534. Epub 2025 Feb 20.
9
Recent Advances in Strategies to Enhance Photodynamic and Photothermal Therapy Performance of Single-Component Organic Phototherapeutic Agents.增强单组分有机光治疗剂光动力和光热治疗性能策略的最新进展
Adv Sci (Weinh). 2025 Feb;12(7):e2409157. doi: 10.1002/advs.202409157. Epub 2025 Jan 10.
10
Capped Plasmonic Gold and Silver Nanoparticles with Porphyrins for Potential Use as Anticancer Agents-A Review.卟啉包覆的金和银等离子体纳米颗粒作为潜在抗癌剂的研究综述
Pharmaceutics. 2024 Sep 28;16(10):1268. doi: 10.3390/pharmaceutics16101268.